Skip to main content
Premium Trial:

Request an Annual Quote

Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer

NEW YORK (GenomeWeb News) – Trovagene today said that it has entered into an R&D agreement with PerkinElmer Health Sciences to design an assay for evaluating a patient's risk of developing hepatocellular carcinoma.

The assay will be based on Trovagene's TrNA technology, the company said in a document filed with the US Securities and Exchange Commission, adding that both firms will jointly validate the assay and evaluate the possibility of combining the TrNA technology with PerkinElmer's technology for automation of nucleic acid isolation.

Trovagene's TrNA, or transrenal nucleic acid, testing technology is based on a method of nucleic acid isolation followed by the detection of specific genetic markers. The technology, according to the San Diego-based firm, can be used for a broad variety of medical conditions.

Under the terms of the deal, PerkinElmer will pay Trovagene milestone payments. PerkinElmer also has received an exclusive option to obtain a royalty-bearing license to use Trovagene's technology within the area of hepatocelluar carcinoma, as well as an exclusive option to obtain a royalty-bearing license to use Trovagene's technology in fields other than hepatocellular carcinoma.

Under certain conditions Trovagene has the option to obtain a royalty-bearing license to PerkinElmer's interest in any invention and/or intellectual property.

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.